doi: 10.1016/j.tranon.2022.101482 62 ZupaniDVeraniPKocjanJJeJPavlinDNovakPet al
The initial screening provides identification only
As epitalon has been shown to bind to H1 (Khavinson et al 2020) it is possible that peptide may downregulate telomerase in cancer cells (through H1 binding and H19 upregulation), and activate ALT (through protein trapping) at the same time
As noted, however, the peptide has exhibited minor to no side effects when administered to both animal subjects and humans, across a variety of research settings and dosages
Avoid selfsourcing, untested vials, and multimonth cycles without medical monitoring
Diaz Vivancos P, Wolff T, Markovic J, Pallardo FV, Foyer CH (2010) A nuclear glutathione cycle within the cell cycle